Atlas Trials

Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)

Clinical trial NCT06141837 · COMPLETED

Trial details

NCT number
NCT06141837
Sponsor
Central Hospital, Nancy, France
Status
COMPLETED
Study type
OBSERVATIONAL
Pseudomonas AeruginosaCOVID-19
Start date
2023-12-01
Primary completion
2024-03-31
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.